11/13/2024
4:44 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:45 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:46 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:46 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
7:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
1:47 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
10/31/2024
7:59 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
11:50 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/07/2024
10:37 AM | FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/04/2024
5:01 PM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
4:06 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:07 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:09 PM | Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:11 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
5:27 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:28 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:16 AM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
05/29/2024
6:33 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
6:34 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:46 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:47 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:05 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:34 PM | Zentalis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024
3:36 PM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:02 AM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:30 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:14 PM | Zentalis Pharmaceuticals (Filer)
| Form S-3ASR | |
02/29/2024
4:20 PM | Zentalis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:43 PM | Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
7:21 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
02/12/2024
7:22 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:23 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:40 AM | WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024
6:11 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:12 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:13 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:14 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:15 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:16 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:26 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:27 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:26 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:52 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:19 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
7:21 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:47 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free ZNTL Stock Alerts